AAAAAA
Results: 1-25/32
Authors:
EDLER L
KOPPSCHNEIDER A
Citation: L. Edler et A. Koppschneider, STATISTICAL-MODELS FOR LOW-DOSE EXPOSURE, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 405(2), 1998, pp. 227-236
Authors:
QUEISSER W
HARTUNG G
MANEGOLD K
DIEZLER P
HAGMULLER E
EDLER L
BAUER A
PABST T
WOJATSCHEK C
JANSSEN N
Citation: W. Queisser et al., GERMAN ADJUVANT RADIOCHEMOTHERAPY TRIAL IN STAGE-II AND STAGE-III RECTAL-CANCER, Annals of oncology, 9, 1998, pp. 160-160
Authors:
GLEISSNER B
HELLMANN A
BERDEL WE
EDLER L
KOLDEHOFF M
ROST A
OPRI F
FRITZE D
OHL S
Citation: B. Gleissner et al., PHASE I II STUDY OF PACLITAXEL AND 5-FLUOROURACIL AS 2ND-LINE THERAPYIN PATIENTS WITH METASTATIC BREAST-CANCER/, Onkologie, 21(4), 1998, pp. 305-308
Authors:
VONPAWEL J
GATZEMEIER U
MEHL B
EDLER L
BAUMGART J
DRINGS P
Citation: J. Vonpawel et al., CLINICAL-PHASE-II TRIAL OF TREOSULFAN IN PATIENTS WITH NONRESECTABLE NON-SMALL-CELL LUNG-CANCER, Onkologie, 21(4), 1998, pp. 316-319
Authors:
JUNG D
BERG PA
EDLER L
EHRENTHAL W
FENNER D
FLESCHJANYS D
HUBER C
KLEIN R
KOITKA C
LUCIER G
MANZ A
MUTTRAY A
NEEDHAM L
PAPKE O
PIETSCH M
PORTIER C
PATTERSON D
PRELLWITZ W
ROSE DM
THEWS A
KONIETZKO J
Citation: D. Jung et al., IMMUNOLOGICAL FINDINGS IN WORKERS FORMERLY EXPOSED TO 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN AND ITS CONGENERS, Environmental health perspectives, 106, 1998, pp. 689-695
Authors:
DANIELSSEN DS
EDLER L
FONSELIUS S
HERNROTH L
OSTROWSKI M
SVENDSEN E
TALPSEPP L
Citation: Ds. Danielssen et al., OCEANOGRAPHIC VARIABILITY IN THE SKAGERRAK AND NORTHERN KATTEGAT, MAY-JUNE, 1990, ICES journal of marine science, 54(5), 1997, pp. 753-773
Authors:
HARTUNG G
MAAS K
EDLER L
DIEZLER P
HAGMULLER E
PASTERNAK L
QUEISSER W
Citation: G. Hartung et al., ADJUVANT CHEMOTHERAPY OF DUKES-C COLON-CARCINOMA - COMPARISON OF 5-FUPLUS LEVAMISOLE (LEV) 12 MONTHS VS. 5-FU PLUS FOLINIC ACID (FA) 12 MONTHS VS 5-FU PLUS FA 6 MONTHS, European journal of cancer, 33, 1997, pp. 751-751
Authors:
HARTUNG G
QUEISSER W
MAAS K
DIEZLER P
HAGMULLER E
EDLER L
KOPPSCHNEIDER A
WENIGER J
BAUR A
PABST T
JACOB I
WOJATSCHEK C
SEIFERT A
WEH HJ
JANSSEN N
ENGEL M
DROST H
STOCKERT H
LEHNIGK S
Citation: G. Hartung et al., ADJUVANT RADIOCHEMOTHERAPY WITH 5-FLUOROURACIL AND FOLINIC ACID IN STAGE-II AND STAGE-III RECTAL-CANCER - INTERIM ANALYSIS, Onkologie, 20(3), 1997, pp. 231-234
Authors:
JUNG D
BECHER H
EDLER L
FLESCHJANYS D
GURN P
KONIETZKO J
MANZ A
PAPKE O
Citation: D. Jung et al., ELIMINATION OF BETA-HEXACHLOROCYCLOHEXANE IN OCCUPATIONALLY EXPOSED PERSONS, Journal of toxicology and environmental health, 51(1), 1997, pp. 23-34
Authors:
VOLM M
ZINTL F
EDLER L
SAUERBREY A
Citation: M. Volm et al., PROGNOSTIC VALUE OF PROTEIN-KINASE-C, PROTOONCOGENE PRODUCTS AND RESISTANCE-RELATED PROTEINS IN NEWLY-DIAGNOSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Medical and pediatric oncology, 28(2), 1997, pp. 117-126
Authors:
KARLSON B
EDLER L
GRANELI W
SAHLSTEN E
KUYLENSTIERNA M
Citation: B. Karlson et al., SUBSURFACE CHLOROPHYLL MAXIMA IN THE SKAGERRAK - PROCESSES AND PLANKTON COMMUNITY STRUCTURE, Journal of sea research, 35(1-3), 1996, pp. 139-158
Authors:
KINSCHERF R
HACK V
FISCHBACH T
FRIEDMANN B
WEISS C
EDLER L
BARTSCH P
DROGE W
Citation: R. Kinscherf et al., LOW PLASMA GLUTAMINE IN COMBINATION WITH HIGH GLUTAMATE LEVELS INDICATE RISK FOR LOSS OF BODY CELL MASS IN HEALTHY-INDIVIDUALS - THE EFFECTOF N-ACETYL-CYSTEINE, Journal of molecular medicine, 74(7), 1996, pp. 393-400
Authors:
HANAUSKE AR
EDLER L
Citation: Ar. Hanauske et L. Edler, NEW CLINICAL-TRIAL DESIGNS FOR PHASE-I STUDIES IN HEMATOLOGY AND ONCOLOGY - PRINCIPLES AND PRACTICE OF THE CONTINUAL REASSESSMENT MODEL, Onkologie, 19(5), 1996, pp. 404-409
Authors:
FIEBIG HH
HENSS H
VONPAWEL L
GATZEMEIER U
MANEGOLD C
EDLER L
BERDEL W
Citation: Hh. Fiebig et al., PHASE-II CLINICAL-TRIAL OF LOBAPLATIN (D-19466) IN PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER, Onkologie, 19(4), 1996, pp. 328-332
Authors:
MANEGOLD C
DRINGS P
GATZEMEIER U
VONPAWEL J
FIEBIG HH
QUEISSER W
EDLER L
Citation: C. Manegold et al., LOBAPLATIN (D-19466) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A TRIAL OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY (AIO) PHASE-II STUDY-GROUP, Onkologie, 19(3), 1996, pp. 248-251
Authors:
HARTUNG G
QUEISSER W
DIEZLER P
HAGMULLER E
EDLER L
JACOB I
WOJATSCHEK C
SEIFERT A
WEISS H
WEH HJ
HOFFKNECHT M
CLEMENS MR
FRITZE D
KATZ R
HARLE M
Citation: G. Hartung et al., ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL AND FOLINIC ACID IN COLORECTAL-CANCER - EVALUATION OF TOXICITY, Onkologie, 19(1), 1996, pp. 62-67
Authors:
FOX G
POPANDA O
EDLER L
THIELMANN HW
Citation: G. Fox et al., PREFERENTIAL INHIBITION OF DNA-POLYMERASE-ALPHA, DNA-POLYMERASE-DELTA, AND DNA-POLYMERASE-EPSILON FROM NOVIKOFF HEPATOMA-CELLS BY INHIBITORS OF CELL-PROLIFERATION, Journal of cancer research and clinical oncology, 122(2), 1996, pp. 78-94
Authors:
PORTIER CJ
SHERMAN CD
KOHN M
EDLER L
KOPPSCHNEIDER A
MARONPOT RM
LUCIER G
Citation: Cj. Portier et al., MODELING THE NUMBER AND SIZE OF HEPATIC FOCAL LESIONS FOLLOWING EXPOSURE TO 2,3,7,8-TCDD, Toxicology and applied pharmacology, 138(1), 1996, pp. 20-30
Authors:
SAUERBREY A
VOLM M
EDLER L
ZINTL F
Citation: A. Sauerbrey et al., PROGNOSTIC VALUE OF PROTEIN-KINASE-C, PROTOONCOGENE PRODUCTS AND RESISTANCE RELATED PROTEINS IN NEWLY-DIAGNOSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 88(10), 1996, pp. 1438-1438
Authors:
HEIM ME
CLEMENS MR
QUEISSER W
PECHERSTORFER M
BOEWER C
HEROLD M
FRANKE A
HERRMANN Z
LOOSE R
EDLER L
Citation: Me. Heim et al., PROSPECTIVE RANDOMIZED TRIAL OF DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN PATIENTS WITH MULTIPLE-MYELOMA REQUIRING TREATMENT - A MULTICENTER STUDY, Onkologie, 18(5), 1995, pp. 439-448
Authors:
HARTUNG G
WEIGOLD A
OHL S
ESSERS U
HEIM ME
FRITZE D
BALDUS M
HOELZER D
BREMER K
QUARDER O
EDLER L
QUEISSER W
Citation: G. Hartung et al., PHASE-II STUDY OF SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES (FAB TYPE-I AND II) - A TRIAL OF THE PHASE-I PHASE-II STUDY-GROUP OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY OF THE GERMAN-CANCER-SOCIETY, Onkologie, 18(5), 1995, pp. 451-455
Authors:
KLEEBERG UR
GAWLIK C
BROCKER EB
BOEWER C
CHATELAIN RP
QUEISSER W
WESTERHAUSEN M
ROTHE B
FRIEDRICH G
EDLER L
Citation: Ur. Kleeberg et al., INTERFERON-ALPHA-2B AND FOTEMUSTINE IN PATIENTS WITH DISSEMINATED MELANOMA - A MULTICENTER PHASE-II TRIAL OF THE AIO PHASE-I PHASE-II STUDY-GROUP OF THE GERMAN-CANCER-SOCIETY, Onkologie, 18(5), 1995, pp. 456-461
Authors:
HERRMANN R
MROSS K
KLEEBERG U
BECHER R
EDLER L
QUEISSER W
LIATI P
KERPELFRONIUS S
Citation: R. Herrmann et al., 4'-IODO-4'-DEOXYDOXORUBICIN (IDX) IN COLORECTAL-CANCER - A MULTICENTER PHASE-II STUDY, Onkologie, 18(1), 1995, pp. 28-30
Authors:
THIELMANN HW
POPANDA O
EDLER L
BOING A
JUNG EG
Citation: Hw. Thielmann et al., DNA-REPAIR SYNTHESIS FOLLOWING IRRADIATION WITH 254-NM AND 312-NM ULTRAVIOLET-LIGHT IS NOT DIMINISHED IN FIBROBLASTS FROM PATIENTS WITH DYSPLASTIC NEVUS SYNDROME, Journal of cancer research and clinical oncology, 121(6), 1995, pp. 327-337
Authors:
GEHRING M
BERTHOLD F
EDLER L
SCHWAB M
AMLER LC
Citation: M. Gehring et al., THE 1P DELETION IS NOT A RELIABLE MARKER FOR THE PROGNOSIS OF PATIENTS WITH NEUROBLASTOMA, Cancer research, 55(22), 1995, pp. 5366-5369